0
Skip to Content
Home
Company
About Us
Careers
Investor Relations
Our Science
Our Technologies
Seqitope®
Opti-mAb®
News
Contact
Open Menu
Close Menu
Open Menu
Close Menu
Home
Company
About Us
Careers
Investor Relations
Our Science
Our Technologies
Seqitope®
Opti-mAb®
News
Contact
Home
Folder:
Company
Back
About Us
Careers
Investor Relations
Folder:
Our Science
Back
Our Technologies
Seqitope®
Opti-mAb®
News
Contact
Jul 2
Written By
Maria L Knudsen
Maria L Knudsen
Next
Next
AAX Biotech announces collaboration with research group at Karolinska Institutet on high-throughput characterization of novel TROP2-targeting antibodies